Title : hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway.

Pub. Date : 2020 Nov 26

PMID : 33242103






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we constructed sorafenib-loaded polyethylene glycol-b-PLGA polymer nanoparticles modified with antibody hGC33 to glypican-3 (GPC3 +), a membrane protein overexpressed in hepatocellular carcinoma. Sorafenib glypican 3 Mus musculus
2 Here, we constructed sorafenib-loaded polyethylene glycol-b-PLGA polymer nanoparticles modified with antibody hGC33 to glypican-3 (GPC3 +), a membrane protein overexpressed in hepatocellular carcinoma. Sorafenib glypican 3 Mus musculus